A widely used homeopathic nasal spray is being recalled across the United States after the Food and Drug Administration found mold and bacterial contamination today.
The product, known as ReBoost Nasal Spray, has been sold in major retail chains and online marketplaces for the past two years without adverse events.
Consumers have been advised to stop using the spray immediately and to return the bottle to the original retailer for a full refund the past.
The recall covers one specific lot, identified by lot number 224268, which expires in December 2027 and is packaged in 20mL bottles sold through retailers.
Recall Details
The voluntary recall was announced by MediNatura New Mexico on Wednesday, following an FDA announcement that the product had contamination issues in the lot today.
The FDA identified yeast or mold and unsafe levels of the bacteria Achromobacter in the recalled product that could pose health risks for consumers today.
According to the FDA, there is a reasonable probability that people who are immuno‑compromised could experience adverse health problems or life‑threatening infections following use today.
The recall is limited to the single lot, but the company is offering refunds to all customers who purchased the product through any retail channel.
FDA Findings
The FDA’s inspection revealed the presence of yeast or mold, which is not permitted in nasal spray products in any sterile formulation for consumer use.
In addition, the bacterial species Achromobacter was detected at unsafe levels, posing health risks for individuals with weakened immune systems that may require medical attention.
The FDA’s statement highlights that immuno‑compromised users face a higher risk of serious infections if the contaminated product is used during the recall today.
The product’s expiration date is December 2027, and the lot number 224268 identifies the affected batch to ensure accurate identification during the recall process today.
Safety Concerns
The FDA’s assessment indicated that the presence of mold could cause allergic reactions or respiratory irritation especially in individuals with conditions that may worsen symptoms.
The bacterial contamination with Achromobacter could lead to infections that are difficult to treat and may require hospitalization especially for patients with chronic illnesses today.
The FDA warned that immuno‑compromised users face a higher risk of serious infections if the contaminated product is used and to seek medical attention today.
The recall notice emphasizes that no adverse events have been reported since the recall began, underscoring its commitment to safety and maintain consumer trust today.
Customer Actions
Customers can return the product to any of these retailers for a full refund, as the recall notice states to ensure a smooth and process.
The recall notice advises that the product can be identified by its lot number, expiration date, and bottle label to ensure accurate returns for customers.
The FDA statement notes that no adverse events have been reported since the recall began and the company is monitoring the situation closely for safety.
MediNatura New Mexico stated that the recall is voluntary and was undertaken “out of an abundance of caution and care” for consumers to ensure product safety.
Company Response
MediNatura New Mexico highlighted that the product had been on the market for two years without any reported adverse events and that it remains safe.
The company stated that the recall was carried out voluntarily “out of an abundance of caution and care” to protect consumers and ensure product integrity.
Customers are encouraged to return the product to any participating retailer for a full refund, with the company covering the cost to facilitate a process.
The company emphasized that no adverse events have been reported since the recall began, underscoring its commitment to safety and to maintain consumer trust today.
Product Details
ReBoost Nasal Spray is a homeopathic product marketed to temporarily relieve nasal congestion, sinus headache, and other upper‑airway symptoms such as postnasal drip and sneezing.
Each bottle contains 20mL of the nasal spray and is packaged with a unique lot number for traceability to assist regulatory and consumer tracking today.
The product’s expiration date is December 2027, and the lot number 224268 identifies the affected batch to ensure accurate identification during the recall process today.
The recall notice encourages consumers to verify the lot number and expiration date before returning the product to ensure a smooth refund experience for customers.
Distribution
ReBoost was distributed nationwide through retailers such as CVS, Walmart, and Amazon, making it widely available to consumers across all major shopping channels for access.
Customers can return the product to any of these retailers for a full refund, as the recall notice states to ensure a smooth and process.
The recall applies to the lot with the number 224268, which can be identified on the bottle label and carton consumers in locating the product.
Retailers will process refunds on the day of return, ensuring customers receive compensation promptly and maintain confidence in product safety and brand integrity for buyers.
Recall Process
The recall was voluntarily initiated by MediNatura New Mexico, as stated in the FDA announcement to address safety concerns and protect consumers from potential harm.
The FDA’s statement includes a warning that immuno‑compromised users face a higher risk of serious infections if the contaminated product is used during the recall.
No adverse events have been reported related to the recalled product since the FDA announced the recall and the company continues to monitor the situation.
The recall notice urges consumers to return the product for a refund and to seek medical attention if symptoms develop especially for those with health.
Key Takeaways
- ReBoost Nasal Spray is voluntarily recalled due to mold and bacterial contamination.
- Consumers must immediately stop use and return the product for a full refund.
- No adverse events have been reported, and the recall is conducted out of caution.
Closing
Consumers should immediately stop using the recalled ReBoost Nasal Spray and return it to the retailer for a full refund to ensure safety and compliance.
MediNatura New Mexico emphasized that the recall was conducted voluntarily “out of an abundance of caution and care” to protect consumers and maintain public trust.
The FDA warned that immuno‑compromised individuals face a higher risk of serious infections if they use the contaminated product and should seek medical attention promptly.
No adverse events have been reported since the recall began, underscoring the company’s commitment to safety and consumer protection and to uphold product integrity today.
